unknown
Stage
About
Develops heart tissue grown from stem cells intended to be used as a cardiac patch for regenerative treatment of heart disease. The company focuses on stem-cell-derived tissue constructs for applications in cardiology.
Explore APHAIA PHARMA AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.